Xylitol is a valuable product, largely employed as a sweetener in food, dentistry and pharmaceutical formulations ([@b8], [@b13]). In spite of the natural occurrence of xylitol in fruits, its extraction is uneconomical ([@b9]). Besides a chemical process which is industrially applied, xylitol can be produced by a biotechnological means in which a strain of *Candida guilliermondii* is used. The yeast, as any pentose-fermenting or pentose-utilizing microorganism, has the xylose reductase in the cytoplasm, which catalyses the conversion of xylose into xylitol ([@b2]). Nevertheless, the xylose/xylitol conversion, through the fermentative process, presents, as limiting factors, the precise control of culture conditions (pH, temperature, agitation, absence of cell inhibitors, etc.), expensive nutrients, huge water consumption and the type of process ([@b13]). As xylitol is a compound of high value, many studies have been done to establish the best condition to perform the biotechnological process ([@b13]). Xylose reductase is not available commercially despite the several studies found in the literature on the potential usage of xylose reductase as well as there being a description of downstream procedures regarding its separation from the yeasts ([@b10]). Consequently, the enzyme must be obtained by cultivating the yeast *Candida guilliermondii* -- which is reported to be one of the most efficient xylitol producers ([@b3], [@b4], [@b7]) - through an aerated batch process, previously established ([@b11]).

However, after the cell disruption and the removal of cell fragments, the xylose reductase has to be separated from the cell-free extract before using it in order to avoid the presence of xylitol dehydrogenase (another natural occurring enzyme in *Candida* genus). This enzyme catalyses the conversion of xylitol to xylulose, leading to the decreasing of the xylose/xylitol yield ([@b4]). The objective of this work was to separate xylose reductase (XR) from xylitol dehydrogenase to explore the maximal efficiency of XR on xylose/xylitol conversion in bioreactors.

Xylose reductase (EC 1.1.1.21) has a molecular weight (MW) of 36 kDa and requires NADPH as cofactor ([@b4], [@b5]). Its use, either in a continuous or a discontinuous bioreactor, constitutes an alternative of economic interest regarding both the catalytic hydrogenation of pure xylose and the fermentation of the xylose present in lignocellulosic hydrolysates (obtained from-sugar cane bagasse, corn or rice straw, etc.) ([@b1]).

Xylose reductase was gotten from *Candida guilliermondii* which has been cultivated as follows ([@b11]): *C. guilliermondii* FTI 20037 was inoculated in the medium formulated with D-xylose (30 g.L^-1^) and supplemented with (NH~4~)~2~SO~4~ (2.0 g.L^-1^), CaCl.2H~2~O (0.1 g.L^-1^), and rice bran extract (10 % v/v). The culture was maintained in a rotating shaker under an agitation of 100 rpm at 30^o^C and pH 5.5. A volume of the yeast suspension containing 0.3x10^8^ cells.mL^-1^ (approximately 1 g.L^-1^) was used to inoculate a fermenter. The fermenter was filled with a synthetic medium, which consisted of xylose (50 g.L^-1^) supplemented with (NH~4~)~2~SO~4~ (2.0 g.L^-1^), CaCl~2~.2H~2~O (0.1 g.L^-1^) and rice bran extract (20 g.L^-1^). The fermentation was performed in a batch process for 34 h at 30°C, pH 5.5 and an agitation of 200 rpm. The cells were harvested by centrifugation at 2700 x g for 15 min, and re-suspended in 0.1 mol. L^-1^ phosphate buffer (pH 7.2). The final suspension (15 g.L^-1^) was stored in a freezer until further procedure.

The cells were suspended in a sterile solution containing a mixture of protease inhibitors (2 mM aminocaproic acid, 10 mM β-mercaptoethanol, 1 mM phenil-methil-sulphonyl-fluoride and 0.2 mM EDTA). A suspension of 1.7 mL (containing 0.2 g cells/mL) was then mixed with 3.30 mL of phosphate buffer (0.1 M; pH 7.2) and submitted to disruption by 20-kHz sonication in 1 s pulses for a period of 45 min (Disrupter VC-100; Sonics & Materials, Newton, CT, USA). Afterwards, the cell fragments were removed by centrifugation (6700 x g for 10 min) at 4°C. The clarified supernatant was used as source of xylose reductase (XR). The XR activity was determined spectrophotometrically (Beckman-Colter, model DU 640) at 340 nm at room temperature ([@b12]). One XR unit (U) was defined as the amount of enzyme which catalyzes the oxidation of 1 μmol NADPH/min. Specific activities were expressed as U.mg~prot~^-1^. Protein concentration was determined by the Bradford assay using bovine serum albumin as a standard (BSA purchased from Sigma Chemical Co. - St. Louis, MO, USA).

The clarified supernatant was submitted to three procedures in order to attain the partially purified XR.

The first one was carried out as described previously by Kostrzynska *et al*. ([@b6]) where an agarose column was used ("green-19" purchased from Sigma Chemical Co. - St. Louis, MO, USA). An aliquot of the supernatant (0.5mL) was poured into a 15 mL tube containing 0.5 mg of agarose which was equilibrated previously with 3 mL of 50 mM phosphate buffer (pH 7.0) for 24 hours. The XR was eluted from the agarose with a 2 M NaCl solution. Afterwards, the enzyme activity and the protein concentration present in the eluate were measured.

The second procedure was consisted of a 10 mL-membrane bioreactor (BMR- Bioengineering membrane reactor, Bioengineering AG, Wald, Germany), which was coupled with an UF-membrane (cut off of 50 kDa, purchased from Millipore - Bedford, MA, USA). An aliquot of 9.5 mL of the supernatant was poured into the reactor which was fed continuously with 10 mM phosphate buffer (pH 7.2) at a feeding rate of 6.0 h^-1^ for 100 minutes. Samples were collected every 5 minutes. Both enzyme activity and the protein concentration were determined in each collected sample.

The third was based on an ultracentrifugation process. The supernatant obtained through the sonication and further centrifugation was diluted to 1:4, 1:5 and 1:10 (v/v). A 10 mL of diluted sample was added into an Amicon Ultra-15 50K NMWL (Nominal Molecular Weight Limit) Centrifugal Filter device and centrifuged at 10.000 x g for 30 minutes at 4°C. Subsequently, the filtrate was collected for further protein and XR activity determinations.

[Table 1](#tbl1){ref-type="table"} shows the activities of XR, the purification factor and the yield attained through the different processes for the partial xylose reductase purification.

###### 

Partial purification of xylose reductase through the agarose column, membrane bioreactor and ultracentrifugation process.

  Procedures                           Specific activity (U/mg protein)   Total activity (U)   Purification factor   Yield (%)
  ------------------------------------ ---------------------------------- -------------------- --------------------- -----------
  Agarose Column                       25.3 x 10^-4^                      12.4 x 10^-2^        2.84                  39.6
  Membrane bioreactor                  27.2 x 10^-4^                      2.29 x 10^-2^        3.05                  7.26
  Ultracentrifugation process (1:10)   12.2 x 10^-3^                      21.3 x 10^-1^        13.7                  67.2

The total and specific activities of xylose reductase before undergoing those procedures were respectively 3.17 x 10^-2^ U and 8.92 x 10^-4^ U/mg of protein. The purification factor was defined as the ratio between the specific activity of purified xylose reductase and the specific activity of xylose reductase before the treatment.

The best result was attained when an ultracentrifugation process was applied (yield of 67% for the sample which was diluted to 1:10). According to the manufacturer, the Amicon Ultra Centrifugal Filter device design incorporates a Millipore Ultracel® regenerated cellulose low binding membrane which provides sample recoveries from dilute and complex sample matrices. The device is characterized by a nominal molecular weight limit which is its ability to retain molecules above a NMWL. By using the filter device, it is supposed to retain XD (63-87 kDa) ([@b3]), at the membrane and as a result, to recover XR (36 kDa) at the bottom of the tube. The activity of XD was also determined to assure that the separation process was successful. By comparing the XR activities before and after the ultracentrifugation procedure, the yield of partial purification of XR for 1:4, 1:5 and 1:10 was 45.6 %, 64.5 % and 67.2 % respectively (data not shown). Both the 1:10 and 1:5 dilutions showed a promising result; except for the first supernatant obtained after disrupting the cells, the activity of XD was not detected in any of the filtrated samples. According to the product information, solutes with a molecular weight close to the NMWL, may only be partially retained. The yield, therefore, might have been influenced by the presence of other proteins and other small impurities with similar molecular weight which competed with XD and kept the enzyme at the membrane. A better result would be achievable as long as the samples were more diluted or pre-purified before the ultracentrifugation.

Although the agarose column showed to be a specific way for purifying XR, as demonstrated by Kostrzynska *et al.* ([@b6]), the intense blue color of the eluted solution interfered sharply on the analytical determinations. In order to proceed with the XR activity and protein measurements, the solution might be highly diluted which would lead to a significant deviation on the accuracy of the analytical procedures.

By using the membrane bioreactor, the purification yield was calculated by the sum of XR activities of each collected sample. However, the XR activity was significantly detected only in the first five collected samples. In the subsequent samples, the XR activity measurement was almost undetectable because the solutions were highly diluted as a consequence of the specific feeding rate employed throughout the ultrafiltration procedure. Therefore, a further concentration of the samples might be necessary to measure, more precisely, the purification yield through this procedure.

The xylose reductase can be partially purified through the downstream procedure: disruption of the yeast cells by sonication in presence of protease inhibitors, followed by centrifugation (10000 x g for 30 min) and ultracentrifugation through a 50 kDa-UF-membrane. It must be considered that the final enzyme solution, prepared as described, does not present xylitol dehydrogenase activity which catalyses the undesirable conversion of xylitol into xylulose. Furthermore, it circumvents an interference of xylitol dehydrogenase (EC 1.1.1.9) (XDH) when a fermentation process is chosen despite its regenerating NADPH ([@b4]).

An alternative and a promising approach of the xylose-xylitol bioconversion would be regenerating the cofactor. As a perspective that follows from the presented achievement, the bioconversion of xylose to xylitol using glucose 6-phosphate dehydrogenase as an auxiliary enzyme to reduce the cofactor NADP to NADPH, has already been evaluated. Thus, the solution containing XR and deprived of XD would be useful for carrying out the xylose/xylitol conversion in a batch or continuous bioreactor. Such an approach might be an alternative for the chemical synthesis and the fermentation process which are largely used currently.
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RESUMO
======

Obtenção de xilose redutase de *Candida guilliermondii* parcialmente purificada
-------------------------------------------------------------------------------

A bioconversão enzimática da xilose em xilitol pela xilose redutase (XR) é uma alternativa para as vias química e microbiológica. Avaliou-se a purificação parcial da XR, utilizando os três seguintes procedimentos: uma coluna de agarose, um reator com membrana ou tubos de ultracentrifugação Amicon Ultra-15 50K, com rendimento de 40%, 7% ou 67%, respectivamente.
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